CereGate is a neurotechnology company focused on developing a computer-brain interface (CBI) software platform that enhances the capabilities of existing neuromodulation implants and neural devices. The company’s technology layer interfaces with hardware such as deep brain stimulation and spinal cord stimulation systems to enable bidirectional communication with the nervous system.

Its platform is hardware-agnostic and designed to transmit information into the brain, extend the functional applications of implants, and support novel therapeutic protocols for movement, sensory, and neurological disorders. CereGate’s software toolkit includes advanced signal processing, adaptive control, and clinical workflow integration, enabling personalized neuromodulation strategies.

CereGate’s solutions are positioned for clinical application in rehabilitation, movement disorders such as Parkinson’s disease, and sensory restoration scenarios, with ongoing trials and clinical validation. The company situates itself at the intersection of neuromodulation, neural interfaces, and therapeutic software, aiming to expand outcomes from existing implantable technologies.